HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey

Pharma’s reputation is holding steady. That’s according to the annual patient group opinion report from PatientView, which found 41% who rated the pharma industry reputation as “excellent” or “good” in 2018, compared with a similar 43% in 2017. Fifty-three percent of patient groups also rated the industry as excellent or good for the making of… Read More »